Position in ERAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$70,021,109
-$8,859,399 QoQ
Shares Held
3,822,113
-21.6% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 257 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. ERAS ranks #46 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in ERAS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,021,109 | 3,822,113 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $78,880,508 | 4,875,186 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,392,874 | 3,331,418 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $5,487,468 | 2,517,188 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,311,207 | 1,819,849 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,652,670 | 1,936,257 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $7,032,090 | 2,801,630 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $8,818,871 | 3,230,356 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,174,620 | 2,192,636 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,258,952 | 1,582,016 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,762,698 | 1,297,042 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $1,307,782 | 663,850 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $1,737,425 | 629,502 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $2,192,480 | 728,399 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $1,974,432 | 458,105 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $10,963,812 | 1,405,617 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $2,458,503 | 441,383 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $2,964,763 | 344,740 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,094,276 | 70,236 | Shares | Defined | 2022-02-17 | |
| No filing history on record for this holder in this stock. | ||||||